1624P Total and regional changes in body composition in metastatic hormone-sensitive prostate cancer (mHSPC) patients randomized to receive androgen deprivation + enzalutamide +/- zoledronic acid: The BonEnza study
M. Buffoni, Alberto Dalla Volta, Francesca Valcamonico, Duncan Apollo et autres